SHAHUL RIAZUDEEN: Open Payments
NPI 1932163888 · WIMAUMA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 34 payments from 16 companies in 2025. Trend: 2023 $718 · 2024 $630 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $136 |
| Amgen Inc. | 4 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| ABBVIE INC. | 2 | $49 |
| PFIZER INC. | 2 | $47 |
| Dexcom, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Insmed, Inc. | 1 | $27 |
Products named: XIFAXAN, Kerendia, GEMTESA, LEQVIO, OTEZLA, VRAYLAR, ELIQUIS, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
